Ascendis Pharma A/S(ASND)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ASND Ascendis Pharma A/S

交易中 07-22 15:41:40 EDT

137.04

+1.83

+1.35%

最高137.62	最低134.55	成交量22.84万
今开135.67	昨收135.21	日振幅2.27%
总市值78.59亿	流通市值77.98亿	总股本5,735万
成交额3,112万	换手率0.40%	流通股本5,691万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ASND","market":"US","secType":"STK","nameCN":"Ascendis Pharma A/S","latestPrice":137.04,"timestamp":1721677283660,"preClose":135.21,"halted":0,"volume":228430,"delay":0,"floatShares":56906612,"shares":57349754,"eps":-9.57998,"marketStatus":"交易中","marketStatusCode":2,"change":1.83,"latestTime":"07-22 15:41:40 EDT","open":135.67,"high":137.62,"low":134.55,"amount":31120339.2254,"amplitude":0.022705,"askPrice":137.23,"askSize":9,"bidPrice":136.77,"bidSize":119,"shortable":3,"etf":0,"ttmEps":-9.57998,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1721678400000},"adr":1,"listingDate":1422421200000,"adjPreClose":135.21,"adrRate":1,"postHourTrading":{"tag":"盘后","latestPrice":136,"preClose":135.21,"latestTime":"18:27 EDT","volume":31569,"amount":4268686.18,"timestamp":1721428049544},"volumeRatio":0.667671,"impliedVol":0.7421,"impliedVolPercentile":0.8327},"requestUrl":"/m/hq/s/ASND/wiki","defaultTab":"wiki","newsList":[{"id":"2446784604","title":"Ascendis Pharma A/S盘中异动 早盘快速上涨6.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446784604","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446784604?lang=zh_cn&edition=full","pubTime":"2024-06-25 21:30","pubTimestamp":1719322248,"startTime":"0","endTime":"0","summary":"北京时间2024年06月25日21时30分，Ascendis Pharma A/S股票出现异动，股价快速拉升6.58%。Ascendis Pharma A/S股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Glycomimetics, Inc.、Senti Biosciences, Inc.、Anew Medical, Inc.涨幅较大，Effector Therapeutics, Inc.、Glycomimetics, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为84.60%、75.49%、56.15%，振幅较大的相关个股有Lipella Pharmaceuticals Inc.、Allarity Therapeutics, Inc.、Glycomimetics, Inc.，振幅分别为12.48%、6.65%、6.04%。Ascendis Pharma A/S公司简介：Ascendis Pharma A/S 是一家生物制药公司。该公司的产品线包括 Transcon 生长激素、Transconpeptides、Transcon PTH、Transcon CNP 等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625213048aef686cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240625213048aef686cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0109394709.USD","LU0320765992.SGD","BK4139","BK4585","LU0889565916.HKD","ASND"],"gpt_icon":0},{"id":"2445379438","title":"Ascendis Pharma A/S盘中异动 临近收盘股价大涨5.24%报127.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2445379438","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445379438?lang=zh_cn&edition=full","pubTime":"2024-06-22 03:51","pubTimestamp":1718999495,"startTime":"0","endTime":"0","summary":"北京时间2024年06月22日03时51分，Ascendis Pharma A/S股票出现波动，股价大幅拉升5.24%。截至发稿，该股报127.99美元/股，成交量22.7088万股，换手率0.40%，振幅5.19%。Ascendis Pharma A/S股票所在的生物技术行业中，整体跌幅为0.13%。Ascendis Pharma A/S公司简介：Ascendis Pharma A/S 是一家生物制药公司。该公司的产品线包括 Transcon 生长激素、Transconpeptides、Transcon PTH、Transcon CNP 等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240622035135aef6105c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240622035135aef6105c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ASND","BK4139","LU0889565916.HKD","BK4585","LU0320765992.SGD","LU0109394709.USD"],"gpt_icon":0},{"id":"2442556313","title":"Ascendis Pharma A/S盘中异动 股价大跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2442556313","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442556313?lang=zh_cn&edition=full","pubTime":"2024-06-12 22:41","pubTimestamp":1718203300,"startTime":"0","endTime":"0","summary":"北京时间2024年06月12日22时41分，Ascendis Pharma A/S股票出现波动，股价急速下跌5.02%。截至发稿，该股报125.31美元/股，成交量13.6025万股，换手率0.24%，振幅6.58%。Ascendis Pharma A/S股票所在的生物技术行业中，整体涨幅为0.94%。Ascendis Pharma A/S公司简介：Ascendis Pharma A/S 是一家生物制药公司。该公司的产品线包括 Transcon 生长激素、Transconpeptides、Transcon PTH、Transcon CNP 等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612224140941ee19c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612224140941ee19c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ASND","BK4139","LU0889565916.HKD","BK4585","LU0320765992.SGD","LU0109394709.USD"],"gpt_icon":0},{"id":"2437029004","title":"Ascendis Pharma A/S盘中异动 股价大涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2437029004","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437029004?lang=zh_cn&edition=full","pubTime":"2024-05-22 23:37","pubTimestamp":1716392225,"startTime":"0","endTime":"0","summary":"北京时间2024年05月22日23时37分，Ascendis Pharma A/S股票出现异动，股价快速上涨5.05%。截至发稿，该股报129.06美元/股，成交量43.5482万股，换手率0.76%，振幅5.05%。Ascendis Pharma A/S股票所在的生物技术行业中，整体涨幅为0.45%。Ascendis Pharma A/S公司简介：Ascendis Pharma A/S 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240522233705af89b16c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240522233705af89b16c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0889565916.HKD","BK4585","BK4139","ASND","LU0320765992.SGD","LU0109394709.USD"],"gpt_icon":0},{"id":"2436607300","title":"大摩：维持Ascendis Pharma(ASND.US)评级，由持股观望调整至持股观望评级, 目标价由116.00美元调整至140.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2436607300","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2436607300?lang=zh_cn&edition=full","pubTime":"2024-05-17 00:15","pubTimestamp":1715876133,"startTime":"0","endTime":"0","summary":"大摩：维持Ascendis Pharma(ASND.US)评级，由持股观望调整至持股观望评级, 目标价由116.00美元调整至140.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405170015388b0f852e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405170015388b0f852e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ASND"],"gpt_icon":0},{"id":"2435554449","title":"Ascendis Pharma A/S盘中异动 下午盘股价大跌5.30%报125.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435554449","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435554449?lang=zh_cn&edition=full","pubTime":"2024-05-15 02:32","pubTimestamp":1715711567,"startTime":"0","endTime":"0","summary":"北京时间2024年05月15日02时32分，Ascendis Pharma A/S股票出现异动，股价快速下跌5.30%。截至发稿，该股报125.03美元/股，成交量33.0428万股，换手率0.58%，振幅5.47%。Ascendis Pharma A/S股票所在的生物技术行业中，整体涨幅为0.17%。Ascendis Pharma A/S公司简介：Ascendis Pharma A/S 是一家生物制药公司。该公司的产品线包括 Transcon 生长激素、Transconpeptides、Transcon PTH、Transcon CNP 等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051502324787e87dcc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051502324787e87dcc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ASND","LU0889565916.HKD","LU0320765992.SGD","BK4585","LU0109394709.USD"],"gpt_icon":0},{"id":"2432904334","title":"坎托菲茨杰拉德公司：重申Ascendis Pharma(ASND.US)评级，由增持调整至增持评级, 目标价173.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2432904334","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432904334?lang=zh_cn&edition=full","pubTime":"2024-05-03 23:05","pubTimestamp":1714748732,"startTime":"0","endTime":"0","summary":"坎托菲茨杰拉德公司：重申Ascendis Pharma(ASND.US)评级，由增持调整至增持评级, 目标价173.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405032305348b70aca8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405032305348b70aca8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ASND"],"gpt_icon":0},{"id":"2422535118","title":"维升药业三冲港交所IPO：增高针数据不及竞品前景待考","url":"https://stock-news.laohu8.com/highlight/detail?id=2422535118","media":"华尔街见闻","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2422535118?lang=zh_cn&edition=full","pubTime":"2024-03-25 09:50","pubTimestamp":1711331414,"startTime":"0","endTime":"0","summary":"失之毫厘，差之千里？","market":"hk","thumbnail":"https://wpimg-wscn.awtmt.com/content_default_5.jpg","type":0,"news_type":0,"thumbnails":["https://wpimg-wscn.awtmt.com/content_default_5.jpg"],"rights":{"source":"wallstreetcn_hot_news","url":"https://wallstreetcn.com/articles/3711208","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3711208","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"wallstreetcn_hot_news","symbols":["IE00BD4GTW91.USD","IE00B7SZLL34.SGD","IE00BD4GTV84.USD","BK4208","BMRN","ASND","CNP","IE00B19Z3B42.SGD","BK4139","LU0889565916.HKD","BK4585","LU0109394709.USD","LU0320765992.SGD","IE00BD4GTT62.SGD","BK4588","IE00B19Z3581.USD","BK4566","IE0002270589.USD"],"gpt_icon":0},{"id":"2415398588","title":"Ascendis Pharma A/S盘中异动 临近收盘急速跳水5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2415398588","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2415398588?lang=zh_cn&edition=full","pubTime":"2024-02-29 04:31","pubTimestamp":1709152307,"startTime":"0","endTime":"0","summary":"北京时间2024年02月29日04时31分，Ascendis Pharma A/S股票出现波动，股价急速下挫5.01%。截至发稿，该股报147.55美元/股，成交量34.9456万股，换手率0.62%，振幅4.50%。Ascendis Pharma A/S股票所在的生物技术行业中，整体跌幅为0.51%。其相关个股中，Vivani Medical Inc、Vtv Therapeutics Inc、Adial Pharmaceuticals Inc涨幅较大，Adial Pharmaceuticals Inc、Vivani Medical Inc、Revelation Biosciences Inc较为活跃，换手率分别为6580.68%、280.20%、183.10%，振幅较大的相关个股有Vivani Medical Inc、Adial Pharmaceuticals Inc、Vtv Therapeutics Inc，振幅分别为424.75%、219.84%、129.29%。Ascendis Pharma A/S公司简介：Ascendis Pharma A/S 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240229043147861d9b3b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240229043147861d9b3b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ASND","LU0889565916.HKD","LU0320765992.SGD","LU0109394709.USD","BK4585","BK4139"],"gpt_icon":0},{"id":"2412667723","title":"Ascendis Pharma A/S盘中异动 早盘股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2412667723","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2412667723?lang=zh_cn&edition=full","pubTime":"2024-02-17 00:21","pubTimestamp":1708100474,"startTime":"0","endTime":"0","summary":"北京时间2024年02月17日00时21分，Ascendis Pharma A/S股票出现波动，股价大幅上涨5.01%。截至发稿，该股报154.57美元/股，成交量14.2446万股，换手率0.25%，振幅6.03%。Ascendis Pharma A/S股票所在的生物技术行业中，整体涨幅为0.25%。Ascendis Pharma A/S公司简介：Ascendis Pharma A/S 是一家生物制药公司。该公司的产品线包括 Transcon 生长激素、Transconpeptides、Transcon PTH、Transcon CNP 等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402170021147911c85f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402170021147911c85f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0889565916.HKD","BK4585","BK4139","ASND","LU0320765992.SGD","LU0109394709.USD"],"gpt_icon":0},{"id":"2410078395","title":"Ascendis Pharma A/S2023财年实现净利润-5.20亿美元，同比增加15.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2410078395","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2410078395?lang=zh_cn&edition=full","pubTime":"2024-02-11 00:23","pubTimestamp":1707582227,"startTime":"0","endTime":"0","summary":"12月31日，Ascendis Pharma A/S公布财报，公告显示公司2023财年净利润为-5.20亿美元，同比增加15.17%；其中营业收入为2.88亿美元，同比增加435.52%，每股基本收益为-9.25美元。从资产负债表来看，Ascendis Pharma A/S总负债10.73亿美元，其中短期债务28.06百万美元，资产负债比为0.85，流动比率为3.56。机构评级：截至2023年12月31日，当前有13家机构对Ascendis Pharma A/S目标价做出预测，其中目标均价为171.27美元，其中最低目标价为116.61美元，最高目标价为225.21美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402110023568180a4ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402110023568180a4ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ASND"],"gpt_icon":0},{"id":"2409761527","title":"美国研究综述-Idexx 实验室、Fleetcor 技术公司、亨廷顿英格尔斯工业公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2409761527","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2409761527?lang=zh_cn&edition=full","pubTime":"2024-02-08 16:00","pubTimestamp":1707379255,"startTime":"0","endTime":"0","summary":"    路透2月8日 - 华尔街证券分析师周四调整了对几家美国上市公司的评级和目标价，其中包括Idexx Laboratories、Fleetcor Technologies和Huntington Ingalls Industries 。股票条目按字母顺序排列。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CFLT","BLBD","AB","HII","CCK","COST","HIG","FOXA","FMC","LU0234570918.USD","AME","BK4588","EEFT","EMR","ENTA","GAIN","BBIO","GL","HLN","CAT","APD","ESS","CDW","ARCC","FORM","CG","FLT","LU2237438978.USD","NVST","SG9999014005.SGD","DAY","BK4023","HAIN","CVS","AZTA","HI","ARM","BK4581","IE00BSNM7G36.USD","BRBR","BK4161","LU0234572021.USD","AIZ","CNO","EQNR","ALL","ME","CENT","EPC","ASND"],"gpt_icon":0},{"id":"2408509766","title":"Ascendis Pharma A/S盘中异动 股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2408509766","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2408509766?lang=zh_cn&edition=full","pubTime":"2024-02-02 02:28","pubTimestamp":1706812098,"startTime":"0","endTime":"0","summary":"北京时间2024年02月02日02时28分，Ascendis Pharma A/S股票出现异动，股价大幅拉升5.04%。截至发稿，该股报136.48美元/股，成交量14.6935万股，换手率0.26%，振幅5.51%。Ascendis Pharma A/S股票所在的生物技术行业中，整体涨幅为0.87%。其相关个股中，Protagenic Therapeutics Inc C/Wts 29/04/2026 、Neurobo Pharmaceuticals Inc、Gri Bio Inc涨幅较大，Gri Bio Inc、Neurobo Pharmaceuticals Inc、Revelation Biosciences Inc较为活跃，换手率分别为2664.31%、1185.14%、1025.74%，振幅较大的相关个股有Gri Bio Inc、Kiora Pharmaceuticals Inc、Neurobo Pharmaceuticals Inc，振幅分别为207.75%、69.32%、64.22%。Ascendis Pharma A/S公司简介：Ascendis Pharma A/S 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240202022818790e446e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240202022818790e446e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320765992.SGD","BK4585","LU0109394709.USD","LU0889565916.HKD","BK4139","ASND"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ascendispharma.com","stockEarnings":[{"period":"1week","weight":-0.0208},{"period":"1month","weight":0.0976},{"period":"3month","weight":-0.0354},{"period":"6month","weight":0.0242},{"period":"1year","weight":0.5013},{"period":"ytd","weight":0.0735}],"compareEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":0.0009},{"period":"3month","weight":0.1087},{"period":"6month","weight":0.138},{"period":"1year","weight":0.2141},{"period":"ytd","weight":0.155}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Ascendis Pharma A/s成立于2006年9月21日。该公司是一家临床阶段的生物制药公司，该公司运用其TransCon技术开发具有最佳的长效药物疗法的管道以解决大市场显著未满足的医疗需求。该公司正在开发其先导候选产品，TransCon人生长激素或生长激素TransCon，每周一次给药治疗生长激素缺乏症以及其他疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.037189},{"month":2,"riseRate":0.5,"avgChangeRate":0.037735},{"month":3,"riseRate":0.5,"avgChangeRate":0.039038},{"month":4,"riseRate":0.3,"avgChangeRate":-0.046884},{"month":5,"riseRate":0.4,"avgChangeRate":0.000611},{"month":6,"riseRate":0.6,"avgChangeRate":0.017012},{"month":7,"riseRate":0.6,"avgChangeRate":0.001101},{"month":8,"riseRate":0.666667,"avgChangeRate":0.086396},{"month":9,"riseRate":0.555556,"avgChangeRate":0.037325},{"month":10,"riseRate":0.444444,"avgChangeRate":0.006164},{"month":11,"riseRate":0.777778,"avgChangeRate":0.039978},{"month":12,"riseRate":0.444444,"avgChangeRate":0.049536}],"exchange":"NASDAQ","name":"Ascendis Pharma A/S","nameEN":"Ascendis Pharma A/S"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Ascendis Pharma A/S(ASND)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Ascendis Pharma A/S(ASND)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Ascendis Pharma A/S,ASND,Ascendis Pharma A/S股票,Ascendis Pharma A/S股票老虎,Ascendis Pharma A/S股票老虎国际,Ascendis Pharma A/S行情,Ascendis Pharma A/S股票行情,Ascendis Pharma A/S股价,Ascendis Pharma A/S股市,Ascendis Pharma A/S股票价格,Ascendis Pharma A/S股票交易,Ascendis Pharma A/S股票购买,Ascendis Pharma A/S股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Ascendis Pharma A/S(ASND)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Ascendis Pharma A/S(ASND)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}